The Effect of Home-based Exercise on Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity
The Effect of Home-based Breathing and Chest Mobilisation Exercise on Cardiorespiratory Functional Capacity of Covid-19 Survivor With Cardiovascular Comorbidity
1 other identifier
interventional
46
1 country
1
Brief Summary
Objective propose: to investigate the effect of home based breathing exercise and chest mobilization on the cardiorespiratory functional capacity of Covid-19 survivors with cardiovascular comorbidity. Breathing exercise and chest mobilization are proven to increase lung functional capacity in Covid-19 survivors. It is hypothesized that breathing exercise and chest mobilization in Covid-19 survivors will give benefits to Covid-19 survivors with cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Sep 2021
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedFebruary 23, 2023
February 1, 2023
1.4 years
September 29, 2021
February 21, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Change of Peak Cough Flow (PC)
to define the functional capacity. Unit of measure : L/min.
Change from Baseline Peak Cough Flow (PC) at 3 months
Change of Peak Flow Rate (PFR)
to define the functional capacity. Unit of measure : L/min.
Change from Baseline Peak Flow Rate (PFR) at 3 months
Change of Cardiac Exercise Test
Patients walk on treadmill. Unit of measure : minutes, METs (Metabolic Equivalent of Task)
Change from Baseline Cardiac Exercise Test at 3 months
Change of 6-minutes walking test
To define initial ability to walk in 30 minutes for second phase cardiac rehabilitation (aerobic exercise). Unit of measure : meter
Change from Baseline 6-minutes walking test at 3 months
Secondary Outcomes (17)
Change of Hemoglobin
Change from Baseline Hemoglobin at 3 months
Change of Hematocrit
Change from Baseline Hematocrit at 3 months
Change of Erythrocyte
Change from Baseline Erythrocyte at 3 months
Change of Mean Corpuscular Volume
Change from Baseline Mean Corpuscular Volume at 3 months
Change of Mean Corpuscular Hemoglobin
Change from Baseline Mean Corpuscular Hemoglobin at 3 months
- +12 more secondary outcomes
Study Arms (2)
No Breathing Exercise
ACTIVE COMPARATORPatients will do the second phase of cardiac rehabilitation for minimum 5 times per week, 30 minutes each time, in 3 months without being supervised
With Breathing Exercise
EXPERIMENTALPatients will do the second phase of cardiac rehabilitation for minimum 5 times per week, 30 minutes each time and breathing and chest mobilization exercise for 3 times per week. They will be supervised through online meetings.
Interventions
Patients walk regularly 5 times per week and increase the distance day by day according to their improved ability. Patients also do breathing and chest mobilization exercise 3 times per week. It is a recorded moderated exercise for 30 minutes duration. Patients can access the video as a home-based activity through an online videos platform and will be supervised.
Independently, patients walk regularly 5 times per week and increase the distance day by day according to their improved ability without breathing and chest mobilization exercise.
Eligibility Criteria
You may qualify if:
- Patients who got infected by Covid-19 in 3 months before recruitment and suffering cardiovascular disease
- Able to communicate and operate Youtube and Zoom.
You may not qualify if:
- Limitation to move any part of the body that causes the inability to do the instructed exercise.
- Feel pain in extremities (visual analog scale \>3)
- Chronic Obstructive Pulmonary Disease
- Neuromuscular disorder (stroke, peripheral neuropathy with significant motoric control disturbance
- Musculoskeletal disorder (fracture, post amputation, severe arthritis in support joints)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cardiovascular Center Harapan Kita Hospital Indonesia
Jakarta, 11420, Indonesia
Related Publications (10)
1. WHO Indonesia. Coronavirus Disease 2019 (COVID-19) Situation Report-36. [Internet]. WHO; [2020 Dec 2; cited 2021 Feb 12]. Available from: https://www.who.int/indonesia/news/novel-coronavirus/situation-reports
BACKGROUNDHalpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021 Feb;93(2):1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.
PMID: 32729939BACKGROUNDEapen MS, Lu W, Gaikwad AV, Bhattarai P, Chia C, Hardikar A, Haug G, Sohal SS. Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration? Eur Respir J. 2020 Oct 15;56(4):2003167. doi: 10.1183/13993003.03167-2020. Print 2020 Oct.
PMID: 32859681BACKGROUNDAbdullahi A. Safety and Efficacy of Chest Physiotherapy in Patients With COVID-19: A Critical Review. Front Med (Lausanne). 2020 Jul 21;7:454. doi: 10.3389/fmed.2020.00454. eCollection 2020.
PMID: 32793618BACKGROUNDSardari A, Tabarsi P, Borhany H, Mohiaddin R, Houshmand G. Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imaging. 2021 Jan 1;22(1):131-132. doi: 10.1093/ehjci/jeaa166. No abstract available.
PMID: 32462177BACKGROUNDSalman D, Vishnubala D, Le Feuvre P, Beaney T, Korgaonkar J, Majeed A, McGregor AH. Returning to physical activity after covid-19. BMJ. 2021 Jan 8;372:m4721. doi: 10.1136/bmj.m4721. No abstract available.
PMID: 33419740BACKGROUNDOgura A, Izawa KP, Tawa H, Kureha F, Wada M, Harada N, Ikeda Y, Kimura K, Kondo N, Kanai M, Kubo I, Yoshikawa R, Matsuda Y. Impact of the COVID-19 pandemic on phase 2 cardiac rehabilitation patients in Japan. Heart Vessels. 2021 Aug;36(8):1184-1189. doi: 10.1007/s00380-021-01783-5. Epub 2021 Jan 29.
PMID: 33512598BACKGROUNDBarker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31.
PMID: 32475821BACKGROUND9. ESC. Recommendations on how to provide cardiac rehabilitation activities during the COVID-19 pandemic. [Internet] France: European Society of Cardiology; [2020 Apr 8; cited in 2021 Feb 12]. Available from: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/recommendations-on-how-to-provide-cardiac-rehabilitation-activities-during-the-c
BACKGROUNDDwiputra B, Ambari AM, Triangto K, Supriami K, Kesuma TW, Zuhdi N, Phowira J, Radi B. The home-based breathing and chest mobility exercise improves cardiorespiratory functional capacity in long COVID with cardiovascular comorbidities: a randomized study. BMC Cardiovasc Disord. 2024 Oct 18;24(1):574. doi: 10.1186/s12872-024-04196-0.
PMID: 39425012DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bambang Dwiputra, MD, FIHA
National Cardiovascular Center Harapan Kita Hospital Indonesia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD Cardiologist, Principal Investigator
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 14, 2021
Study Start
September 1, 2021
Primary Completion
January 31, 2023
Study Completion
February 20, 2023
Last Updated
February 23, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share